Complete financial analysis of Philip Morris International Inc. (PM) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Philip Morris International Inc., a leading company in the Tobacco industry within the Consumer Defensive sector.
You may be interested
- SEWON E&C CO., Ltd. (091090.KS) Income Statement Analysis – Financial Results
- Shaanxi Kanghui Pharmaceutical Co., Ltd. (603139.SS) Income Statement Analysis – Financial Results
- GigaDevice Semiconductor (Beijing) Inc. (603986.SS) Income Statement Analysis – Financial Results
- CES Energy Solutions Corp. (CEU.TO) Income Statement Analysis – Financial Results
- Visible Gold Mines Inc. (VGMIF) Income Statement Analysis – Financial Results
Philip Morris International Inc. (PM)
About Philip Morris International Inc.
Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products that are sold in markets outside the United States. The company offers its smoke-free products under the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, HEETS FROM MARLBORO, Marlboro Dimensions, Marlboro HeatSticks, Parliament HeatSticks, and TEREA brands, as well as the KT&G-licensed brands, Fiit, and Miix. It also sells its products under the Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris brands. In addition, the company owns various cigarette brands, such as Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia; and Fortune and Jackpot in the Philippines. The company sells its smoke-free products in 71 markets. Philip Morris International Inc. was incorporated in 1987 and is headquartered in New York, New York.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2003 | 2001 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 35.17B | 31.76B | 31.41B | 28.69B | 29.81B | 29.63B | 28.75B | 26.69B | 26.79B | 29.77B | 31.22B | 31.38B | 31.10B | 27.21B | 25.04B | 25.71B | 22.80B | 48.26B | 45.29B | 33.39B | 8.10B |
| Cost of Revenue | 12.89B | 11.23B | 10.03B | 9.57B | 10.51B | 10.76B | 10.43B | 9.39B | 9.37B | 10.44B | 10.41B | 10.37B | 10.68B | 9.71B | 9.02B | 9.33B | 8.72B | 35.62B | 32.92B | 23.82B | 2.81B |
| Gross Profit | 22.28B | 20.53B | 21.38B | 19.13B | 19.29B | 18.87B | 18.32B | 17.29B | 17.43B | 19.33B | 20.81B | 21.00B | 20.42B | 17.50B | 16.01B | 16.38B | 14.08B | 12.64B | 12.37B | 9.57B | 5.30B |
| Gross Profit Ratio | 63.35% | 64.65% | 68.06% | 66.65% | 64.73% | 63.69% | 63.71% | 64.81% | 65.05% | 64.94% | 66.65% | 66.94% | 65.66% | 64.30% | 63.96% | 63.71% | 61.75% | 26.19% | 27.31% | 28.66% | 65.36% |
| Research & Development | 709.00M | 642.00M | 617.00M | 495.00M | 465.00M | 383.00M | 453.00M | 429.00M | 423.00M | 433.00M | 449.00M | 415.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 10.11B | 8.14B | 8.52B | 7.48B | 8.78B | 7.45B | 6.73B | 6.41B | 6.66B | 7.00B | 6.89B | 6.98B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | -148.00M | 8.30B | 7.38B | 8.70B | 7.41B | 6.73B | 6.41B | 6.66B | 7.00B | 6.89B | 6.98B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 10.11B | 7.99B | 8.30B | 7.41B | 8.17B | 7.45B | 6.73B | 6.41B | 6.66B | 7.00B | 6.89B | 6.96B | 6.88B | 6.16B | 5.87B | 6.00B | 5.02B | 4.57B | 4.54B | 3.37B | 0.00 |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -41.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 98.00M | 88.00M | 74.00M | 44.00M | 28.00M | 0.00 | 90.00M | 0.00 | 0.00 |
| Operating Expenses | 10.63B | 8.18B | 8.37B | 7.54B | 8.70B | 7.47B | 6.75B | 6.39B | 6.70B | 7.52B | 7.31B | 7.16B | 6.98B | 6.25B | 5.94B | 6.05B | 5.05B | 4.27B | 4.63B | 3.37B | 2.35B |
| Cost & Expenses | 23.62B | 19.40B | 18.40B | 17.11B | 19.21B | 18.23B | 17.19B | 15.78B | 16.07B | 17.96B | 17.72B | 17.53B | 17.66B | 15.96B | 14.97B | 15.37B | 13.77B | 39.89B | 37.55B | 27.19B | 5.16B |
| Interest Income | 465.00M | 180.00M | 109.00M | 110.00M | 226.00M | 190.00M | 182.00M | 178.00M | 124.00M | 118.00M | 131.00M | 148.00M | 134.00M | 98.00M | 108.00M | 217.00M | 0.00 | 229.00M | 0.00 | 0.00 | 0.00 |
| Interest Expense | 1.53B | 768.00M | 737.00M | 728.00M | 570.00M | 665.00M | 914.00M | 891.00M | 1.13B | 1.17B | 1.10B | 1.01B | 800.00M | 974.00M | 797.00M | 528.00M | 10.00M | 371.00M | 94.00M | 0.00 | 146.00M |
| Depreciation & Amortization | 1.40B | 1.19B | 998.00M | 981.00M | 964.00M | 989.00M | 875.00M | 743.00M | 754.00M | 889.00M | 882.00M | 898.00M | 98.00M | 932.00M | 853.00M | 44.00M | 748.00M | 658.00M | 527.00M | 370.00M | 0.00 |
| EBITDA | 13.37B | 13.79B | 14.17B | 12.92B | 11.95B | 12.58B | 12.46B | 11.71B | 11.47B | 12.67B | 14.48B | 14.85B | 14.48B | 12.19B | 10.94B | 11.09B | 9.64B | 9.23B | 8.26B | 6.57B | 2.95B |
| EBITDA Ratio | 38.02% | 42.88% | 44.81% | 44.26% | 40.34% | 41.60% | 43.06% | 43.31% | 42.71% | 44.10% | 47.11% | 47.31% | 43.89% | 45.12% | 43.63% | 40.69% | 43.57% | 18.08% | 18.44% | 19.67% | 36.36% |
| Operating Income | 12.70B | 12.54B | 13.08B | 11.72B | 11.06B | 11.34B | 11.50B | 10.82B | 10.69B | 12.24B | 13.82B | 13.95B | 13.33B | 11.20B | 10.04B | 10.25B | 8.87B | 8.37B | 7.74B | 6.20B | 2.95B |
| Operating Income Ratio | 36.10% | 39.49% | 41.64% | 40.84% | 37.10% | 38.26% | 40.01% | 40.53% | 39.90% | 41.11% | 44.28% | 44.45% | 42.87% | 41.16% | 40.10% | 39.87% | 38.92% | 17.34% | 17.08% | 18.56% | 36.36% |
| Total Other Income/Expenses | -2.09B | -773.00M | -695.00M | -751.00M | -1.04B | -605.00M | -855.00M | -797.00M | -971.00M | -947.00M | -995.00M | -959.00M | -810.00M | -876.00M | -797.00M | -311.00M | -49.00M | -124.00M | -94.00M | 17.00M | -179.00M |
| Income Before Tax | 10.61B | 11.77B | 12.38B | 10.97B | 10.02B | 10.73B | 10.65B | 10.02B | 9.72B | 10.76B | 12.52B | 12.99B | 12.53B | 10.32B | 9.24B | 9.94B | 8.86B | 8.23B | 7.64B | 6.21B | 2.77B |
| Income Before Tax Ratio | 30.16% | 37.06% | 39.42% | 38.23% | 33.62% | 36.22% | 37.04% | 37.54% | 36.28% | 36.13% | 40.11% | 41.39% | 40.30% | 37.94% | 36.92% | 38.66% | 38.88% | 17.05% | 16.87% | 18.61% | 34.16% |
| Income Tax Expense | 2.34B | 2.24B | 2.67B | 2.38B | 2.29B | 2.45B | 4.31B | 2.77B | 2.69B | 3.10B | 3.67B | 3.83B | 3.65B | 2.83B | 2.69B | 2.79B | 2.56B | 1.83B | 1.84B | 2.09B | 593.00M |
| Net Income | 7.79B | 9.05B | 9.11B | 8.06B | 7.19B | 7.91B | 6.04B | 6.97B | 6.87B | 7.49B | 8.58B | 8.80B | 8.59B | 7.26B | 6.34B | 6.89B | 6.03B | 6.15B | 5.62B | 3.98B | 2.23B |
| Net Income Ratio | 22.15% | 28.49% | 29.00% | 28.08% | 24.11% | 26.70% | 20.99% | 26.11% | 25.65% | 25.17% | 27.47% | 28.05% | 27.63% | 26.68% | 25.33% | 26.80% | 26.43% | 12.74% | 12.41% | 11.91% | 27.50% |
| EPS | 5.02 | 5.82 | 5.83 | 5.16 | 4.61 | 5.09 | 3.88 | 4.48 | 4.42 | 4.76 | 5.26 | 5.17 | 4.98 | 3.93 | 3.25 | 3.33 | 2.86 | 2.91 | 2.71 | 1.96 | 1.34 |
| EPS Diluted | 5.02 | 5.81 | 5.83 | 5.16 | 4.61 | 5.09 | 3.88 | 4.48 | 4.42 | 4.76 | 5.26 | 5.17 | 4.98 | 3.92 | 3.24 | 3.32 | 2.86 | 2.91 | 2.69 | 1.95 | 1.34 |
| Weighted Avg Shares Out | 1.55B | 1.55B | 1.56B | 1.56B | 1.56B | 1.56B | 1.55B | 1.55B | 1.55B | 1.57B | 1.62B | 1.69B | 1.73B | 1.84B | 1.94B | 2.07B | 2.11B | 2.11B | 2.07B | 2.03B | 0.00 |
| Weighted Avg Shares Out (Dil) | 1.55B | 1.55B | 1.56B | 1.56B | 1.56B | 1.56B | 1.55B | 1.55B | 1.55B | 1.57B | 1.62B | 1.69B | 1.73B | 1.84B | 1.95B | 2.08B | 2.11B | 2.11B | 2.09B | 2.04B | 0.00 |
Innovation Titan Philip Morris International Comes To America
Philip Morris is entering the US market, poised to capture significant market share in smoke-free products, challenging Altria and British American Tobacco. PM's strong focus on smoke-free products, with 38% of revenue from SFPs, positions it as a leader in...
Billionaire Stan Druckenmiller Is Selling Nvidia, Apple, and Microsoft, and Buying These High-Yield Dividend Stocks Instead
Stan Druckenmiller caught the AI growth wave early, but now he's jumping off the bandwagon. He sold a big chunk of his stakes in Nvidia, Microsoft, and Apple, preferring high-yield dividend stocks instead.
3 Dividend Kings to Add to Your Portfolio for a Lifetime of Passive Income
Coca-Cola is an unstoppable brand that continues to report excellent financial results. Philip Morris is finding new life thanks to next-gen products.
Is It Time To Start Selling Altria, British American And Philip Morris? 4 Things You Need To Know
Tobacco dividend aristocrats Altria, Philip Morris and British American Tobacco experienced a sharp, isolated decline despite no significant news, suggesting random market noise. All three companies maintain strong dividend safety, low bankruptcy risk, and robust balance sheets, making them dependable...
What Does Philip Morris's Sale of Vectura Group Mean for its Future? (Revised)
PM sells Vectura Group to Molex Asia Holdings amid criticism of its ownership as it seeks to shift from tobacco to healthcare.
4 Upcoming Dividend Increases
My strategy focuses on buying, holding, and adding companies with consistent dividend growth and outperforming benchmarks, ensuring a successful long-term portfolio. I passed on Lam Research due to competition with Applied Materials but added Amphenol for its unique position in...
Going Ex-Dividend
Just over a tenth of the stocks in the S&P 500 are going ex-dividend in the next two weeks. If the ex-dividend date is 9/20/24, for example, you'd need to own shares as of the close on 9/19/24 to capture...
Philip Morris Stock Trading Above 200 & 50-Day SMA: Should You Buy?
Philip Morris is poised for success, bolstered by its robust momentum, commitment to innovative smoke-free solutions and ability to drive profitability.
Billionaire Stanley Druckenmiller Just Added This Hot Dividend Growth Stock to His Portfolio
Philip Morris International is one of the new large positions in Stanley Druckenmiller's family office portfolio. The company is set to grow earnings with the growth of its new-age nicotine product portfolio.
What Does Philip Morris's Sale of Vectura Group Mean for its Future?
PM sells Vectura Group to Molex Asia Holdings amid criticism of its ownership as it seeks to shift from tobacco to healthcare.
Source: https://incomestatements.info
Category: Stock Reports